Clinical trial
Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in…
NCT00153660 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00153660 |
|---|---|
| Title | Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients |
| Official title | A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Naproxen Plus Esomeprazole for Prevention of Recurrent Ulcer Bleeding in Patients With Arthritis and Cardiothrombotic Diseases (NSAID#8 Study) |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Cardiovascular Diseases, Cerebrovascular Disorders |
| Intervention type | Drug |
| Interventions | Celecoxib(drug), Naproxen(drug) |
| Enrollment | 514 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2014 |
| Completion | Dec 1, 2016 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 2, 2017 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: